Join us for the launch of the PrEP Ring Early Market Access Vehicle (EMAV), recently announced by CIFF in partnership with the Global Fund. This initiative will provide up to US$2 million to purchase up to 150,000 dapivirine vaginal rings in countries implementing Global Fund HIV grants.
During the session you’ll hear from advocates about the importance of choices for HIV prevention, a bit of background on the ring itself and future vaginal ring products as well as an overview of the EMAV, how to benefit from it and resources to support countries in developing their requests for and introduction of the ring.
Direct any questions to Kalob Gossett.